Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
50,495,188
-
Number of holders
-
555
-
Total 13F shares, excl. options
-
47,155,221
-
Shares change
-
+345,605
-
Total reported value, excl. options
-
$13,665,037,431
-
Value change
-
+$124,076,612
-
Put/Call ratio
-
1.51%
-
Number of buys
-
262
-
Number of sells
-
-258
-
Price
-
$289.83
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q1 2021
625 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q1 2021.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 555 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47,155,221 shares
of 50,495,188 outstanding shares and own 93.39% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5,591,211 shares), VANGUARD GROUP INC (5,157,076 shares), FMR LLC (2,030,678 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1,378,439 shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1,261,319 shares), STATE STREET CORP (1,150,543 shares), Invesco Ltd. (1,113,359 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (992,180 shares), MARSHALL WACE, LLP (917,056 shares), and AMERIPRISE FINANCIAL INC (908,505 shares).
This table shows the top 555 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.